No black box warning on record for Pirfenidone Capsule, 267 Mg

As of the latest FDA labeling reviewed, Pirfenidone Capsule, 267 Mg (PIRFENIDONE CAPSULE, 267 MG) does not carry a black box warning. Standard warnings and precautions still apply — see the full Pirfenidone Capsule, 267 Mg medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Elevated liver enzymes and drug-induced liver injury: ALT, AST, and bilirubin elevations have occurred with pirfenidone including cases of drug-induced liver injury. In the postmarketing setting, non-serious and serious cases of drug-induced liver injury, including severe liver injury with fatal outcomes, have been reported. Monitor ALT, AST, and bilirubin before and dur

No black box warning on record for Pirfenidone Capsule, 267 Mg

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Elevated liver enzymes and drug-induced liver injury: ALT, AST, and bilirubin elevations have occurred with pirfenidone including cases of drug-induced liver injury. In the postmarketing setting, non-serious and serious cases of drug-induced liver injury, including severe liver injury with fatal outcomes, have been reported. Monitor ALT, AST, and bilirubin before and dur

Pirfenidone Capsule, 267 Mg Black Box Warning

No black box warning on record for Pirfenidone Capsule, 267 Mg

Other warnings & precautions

Pirfenidone Capsule, 267 Mg Black Box Warning

No black box warning on record for Pirfenidone Capsule, 267 Mg

Other warnings & precautions